drugset
Drugs / Donor Lymphocyte Infusion
last change Feb 2003 re-read 3 minutes ago

Donor Lymphocyte Infusion

also known as DLI
Developed for
breast cancer · gestational trophoblastic neoplasm · kidney cancer · leukemia · myelodysplastic syndrome · myeloproliferative neoplasm · neuroblastoma · ovarian cancer
+3 more · plasma cell neoplasm · sarcoma · testicular germ cell tumor
Investigated by
Fred Hutchinson Cancer Center · National Cancer Institute (NCI)

Trials 1

today NCT00003887 · Ph 2
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00003887 Aug 1998 → Feb 2003 breast cancer, gestational trophoblastic neoplasm, kidney cancer, leukemia +7 Fred Hutchinson Cancer Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Donor Lymphocyte Infusion “Donor Lymphocyte Infusion (DLI) as Adoptive Immunotherapy for Relapse Malignancies After Allogeneic Hematopoietic Transplantation” NCT00003887 ↗
Known as DLI “Donor Lymphocyte Infusion (DLI) as Adoptive Immunotherapy for Relapse Malignancies After Allogeneic Hematopoietic Transplantation” NCT00003887 ↗